Breakthrough Biosensor Revolutionizes Early Detection of Breast Cancer
Researchers at NIT Rourkela have developed an innovative, semiconductor-based biosensor for early breast cancer detection. This cost-effective device functions without complex laboratory procedures or chemicals, distinguishing cancerous cells through their interaction with microwave radiation. This technology promises broader accessibility, especially in remote areas.

- Country:
- India
NIT Rourkela researchers have unveiled a groundbreaking semiconductor-based biosensor that can detect breast cancer cells without traditional lab procedures. This novel device distinguishes cancerous from healthy cells using their dielectric properties, potentially transforming early diagnostic methods.
The importance of early detection in combating breast cancer is underscored by the rising number of cases worldwide, particularly in India. Current diagnostic methods often require complex infrastructure and trained personnel, limiting their accessibility in remote areas, an issue exacerbated during the COVID-19 pandemic.
The new biosensor, utilizing Tunnel Field Effect Transistors, demonstrates high sensitivity and precision, distinguishing cancer cells based on their higher dielectric constant. Significantly more affordable than existing methods, it promises to make early breast cancer detection more accessible, even potentially in mobile and home settings.
(With inputs from agencies.)